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Preparation, characterization and antimicrobial assessment 
of selected ciprofloxacin salts
The formation of salts is considered a simple strategy to 
modify the physicochemical properties of active pharma-
ceutical ingredients. In this study, seven novel binary and 
ternary organic salts of ciprofloxacin (CP) were prepared 
with benzoic acid (BA), acetylsalicylic acid (ASA), p-cou-
maric acid (PCMA) and p-aminosalicylic acid (PASA). They 
were characterized by spectroscopic techniques and differ-
ential scanning calorimetry. Solubility and partition coef-
ficients values were also measured. Evaluation of the anti-
microbial activity of the organic salts against Staphylococcus 
aureus and Staphylococcus epidermidis revealed that most of 
the new salts had higher antimicrobial activity than CP-
HCl against both strains. The most active compounds 
against S. epidermidis and S. aureus were CP-PASA and CP-
PCMA, resp., which were up to fourteen times more potent 
than parent CP-HCl. Our findings indicated a strong cor-
relation between the lipophilicity of the formed salts and 
their antimicrobial activity and showed that an optimum 
value of lipophilicity (log P = 0.75) seemed to be necessary 
to maximize the antimicrobial activity. These findings 
highlighted the improved physical, thermal and antimicro-
bial properties of the new salts of CP that can aid in provid-
ing higher bioavailability than CP-HCl.
Keywords: ciprofloxacin, salts, partition coefficient, Staphy-
lococcus aureus, Staphylococcus epidermidis
Ciprofloxacin (CP, Fig. 1) is a broad-spectrum fluoroquinolone antimicrobial agent that 
is widely used for treating various infections (1, 2). CP is effectively soluble at the pH 
 values of most parts of the gastrointestinal tract (GIT) as it is mainly positively charged 
[pKa of the basic amino group is 8.8 (3)]. CP exhibits minimum solubility at its isoelectric 
point (pH 7.4) being a zwitterion (3, 4). Nevertheless, CP was reported to have a good oral 
bioavailability of 60–78 % (5). Organic anion transporters have been shown to actively 
transport CP, thus contributing to the observed, otherwise unexpected, high bioavailability 
(6). Previous reports have shown that concurrent administration of diclofenac sodium (DS) 
with CP resulted in a significant increase in its bioavailability (7). Further investigations 
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from our laboratory, revealed that DS forms ion-pair salts with CP. The resulting salts were 
shown to have modified physicochemical properties, partition coefficient and, to some 
extent, antimicrobial activity (8). Ternary associates, involving one molecule of CP and two 
molecules of DS, have also been shown to form, and, interestingly, possess solubilities 
 different than that of CP or its 1:1 salt. CP has also been reported to form salts with 
 carboxylic acids with a potential improvement of aqueous solubility (4, 9, 10). Although salt 
formation provides a simple strategy with promising potential to favorably modify the 
pharmaceutical properties of the two entities, the correct choice of the organic conjugate 
is crucial to provide salts with improved properties.
In this study, we aimed at preparing new salts of CP with some anionic species. Such 
salts might in principle improve the antimicrobial performance of CP, particularly in topi-
cal and ophthalmic preparations. Topical and ophthalmic drug delivery represent a par-
ticular challenge as the drug should strike the delicate balance between hydrophilicity and 
lipophilicity for the successful transport through the involved tissues (11).
Toward this end, four anionic compounds were particularly chosen with the focus on 
preparing ion pairs with the cationic CP. The model anionic compounds (Fig. 1) were ben-
zoic acid (BA), acetylsalicylic acid (ASA), p-coumaric acid (PCMA) and p-aminosalicylic 
acid (PASA). Interestingly, binary and ternary salts involving CP, PCMA and any of the 
other three anions were formed and exhibited different properties along with promising 
antimicrobial activities.
EXPERIMENTAL
Preparation of binary and ternary salts
CP (purity > 98 %), as the hydrochloride salt (CP-HCl), was kindly supplied by Jordan 
Pharmaceutical Manufacturer (JPM, Jordan) while other compounds were purchased from 
Sigma-Aldrich (USA) and certified to have purities > 98 %. All organic acids were supplied 
in the free acid form except benzoic acid which was employed as sodium benzoate.
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Ciprofloxacin (1.18 g, 3.2 mmol) was dissolved in 40 mL of distilled water. An equimolar 
amount of each among four anion compounds to be tested, benzoic acid (BA), acetyl-
salicylic acid (ASA), p-coumaric acid (PCMA) and p-aminosalicylic acid (PASA), was 
 dissolved in the minimum amount of 20 % (V/V) methanol in water. The two solutions 
were mixed and left in the hood until crystals or a precipitate appeared (2–3 days). The 
obtained solids were isolated by filtration and were left to dry for 3 days in a CaCl2 
 desiccator.
Characterization of prepared salts by FTIR, 1H NMR and DSC
Fourier-transform infrared (FTIR) spectra were recorded using Thermo NICOLET 
NEXUS 670 FTIR spectrometer (ThermoFisher Scientific, USA) with OMNIC software at 4 
cm–1 spectral resolution and 32 scans from 4000 to 400 cm–1 using the standard KBr disc 
method.
For proton nuclear magnetic resonance (1H NMR) analysis of the salts, samples (15 
mg) were dissolved in deuterated dimethyl sulfoxide (DMSO, Sigma-Aldrich) and 1H 
NMR spectra were recorded on a Perkin Elmer 350MHz NMR spectrophotometer (Perkin 
Elmer, USA). The temperature was kept constant at 308 K.
Differential scanning calorimetry (DSC) analysis was carried out using a Mettler To-
ledo DSC823e calorimeter (Mettler Toledo, Switzerland) configured to a Mettler_star soft-
ware system. Samples (4–5 mg) were weighed and scanned in sealed aluminum pans with 
pierced cover. The instrument was calibrated with indium as a reference. Thermograms 
were recorded under a dry nitrogen atmosphere (80 mL min–1), over a temperature range 
of 30–300 °C and at a heating rate of 10 °C min–1.
Melting points were also determined using standard capillary type melting point ap-
paratus.
Solubility and partition coefficient of the prepared salts
Solubility and apparent partition coefficient studies were performed in triplicate as 
previously described (8). Briefly, the excess solid material of CP or any of the prepared salts 
was added to 4 mL of phosphate buffer (pH 6.8), left on a shaker water bath for 24 h and 
then 1 mL was centrifuged. The supernatant (100 µL) was diluted and then injected into 
high-performance liquid chromatography (HPLC). For the determination of partition coef-
ficient values, 2 mL of the remaining supernatant solutions were mixed with 2 mL of octa-
nol for 24 h on a shaker water bath. Aliquots of the aqueous layer were properly diluted 
before being injected into HPLC. Results were reported as apparent log P values.
HPLC analysis
The previously optimized and validated HPLC method (8) was used to determine the 
amount of CP. A Merck Hitachi isocratic HPLC pump, equipped with a Merck UV detector 
(Japan), phenyl 150 x 4.5 mm i.d, 5-µm particle size column (ThermoFisher Scientific, USA) 
were used, and the mobile phase was composed of acetonitrile and 50 mmol L–1 phosphate 
buffer (pH 6.5) in a volume ratio 25:75, with the overall mixture containing 0.2 % (m/V) 
citric acid. The flow rate was maintained at 1.5 mL min–1 and the detection wavelength was 
set at 277 nm. All data were processed using Clarity lite® software.
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Determination of antimicrobial activity
Standard laboratory strains of Staphylococcus aureus (ATCC 6538) and Staphylococcus 
epidermidis (ATCC 14990), bought from ATCC (American Type Culture Collection, Manas-
sas, VA, USA), were studied. Stock cultures were maintained at 4 °C on slopes of nutrient 
agar. Cultures for experiments were prepared by transferring a sample from the stock 
cultures into tryptic soy broth and were standardized to match 0.5 McFarlands to an OD 
at 600 nm of 0.1 (± 0.02) according to Clinical and Laboratories Standards Institute (CLSI) 
2007.
Stock solutions of prepared salts were prepared by dissolving the solid crystalline and 
powdered material in DMSO to get the concentration of 5 mg mL–1, then they were filtered 
twice through a 0.22-µm syringe filter. After that, compounds were freshly diluted with 
tryptic soy broth to yield the required concentration. The concentrations of the tested 
compounds were in the range 200–0.244 µg mL–1. Literature showed that ciprofloxacin 
MICs for S. aureus (ATCC 6538) and S. epidermidis (ATCC 14990) were in the range of 0.25 
and 0.5 µg mL–1 and 0.125–0.3 µg mL–1, resp. (12, 13). These values may differ in different 
labs, thus, the range of 200–0.244 µg mL–1 was selected.
The minimum inhibitory concentration (MIC) of the compounds was determined by 
the NCCLS broth microdilution reference method (14) with slight modification with DMSO 
as the solvent and tested for antibacterial activity as a negative control. Briefly, MIC tests 
were performed in 96-flat bottom microtiter plates (TPP, Switzerland). The ELx800UV 
 universal microplate reader (BioTek, USA) was used to determine the turbidity in the 
wells. Bacterial suspensions were prepared in sterilized distilled water in a concentration 
around 1 × 107 CFU mL–1 which was standardized according to 0.5 McFarland suspensions 
as depicted above. MIC was calculated as the average of two successive concentrations of 
the tested compound showing growth and no growth, recpectively. Control tests for each 
experiment were performed. A positive culture was done to ensure the growth of the 
bacteria in the culture media (i.e., the culture media was properly chosen to give accurate 
results) and thus it is done using the media with the bacteria alone. CP-HCl was used as 
the standard antibacterial agent.
DNA spectroscopic titrations
A stock solution of each of the tested products was prepared by dissolving 8 mg in 0.5 
mL of DMSO, however, CP-HCl was dissolved in distilled water instead of DMSO as it was 
freely soluble in water and not sufficiently soluble in DMSO. Stock solutions were appro-
priately diluted (ca 500 times) in phosphate buffer (pH 6.8) to give acceptable UV absor-
bance values (in the range of 0.5–1) when measured at 330 nm. Diluted solutions (500 µL) 
were transferred to a quartz UV micro-cell. Calf thymus DNA (CT-DNA, Sigma-Aldrich) 
solutions were prepared in Tris buffer (pH 7.4). The DNA solution was added directly to 
the sample cell as well as the reference cell in increments of 50 µL. Solutions were well 
mixed inside the cells and left to stand for 10 min after each addition of the DNA solution. 
The absorbance of the final solution was measured at 330 nm using a Cecil UV/Vis spectro-
photometer (Cecil Instrumentation Services Ltd, UK). Binding curves were obtained for 
each substance by plotting the absorbance value against the molar ratio of CP to DNA (in 
base pairs). Further assessment of the binding process and estimation of the binding con-
stant was based on the procedures adopted by Wolfe et al. (15).
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Overall, seven products were obtained (Table I); some appeared as very fine crystals, 
while the others were apparently amorphous. Four of the products were binary salts, i.e., 
assumed to be composed of CP and either of the four organic acids and thus were labeled 
as CP-PCMA, CP-ASA, CP-PASA and CP-BA. The remaining three products were assumed 
to be ternary structures of CP, PCMA and either ASA, PASA or BA. The products were 
extensively characterized before their antibacterial activity was evaluated as presented in 
the sections that follow.
Melting points and DSC. – Melting points of different compounds are shown in Table I. 
Generally, a combination of CP with four among investigated anions significantly lowers 
the melting point of the formed binary and ternary salts compared to the starting mate-
rial, CP-hydrochloride (CP-HCl) as noted in Table I. The salts exhibited melting points 
within a narrow temperature range which indicates the formation of the hypothesized 
products of reasonable purity. It is noteworthy that ternary complexes exhibited lower 
melting points than their binary counterparts with an exception of ASA compounds which 
exhibited higher melting points when compared to its binary product (Table I). Normally, 
the change in the melting point for salts depends on the type of the anion used, the shape 
and the order of the molecules in the salts, and the force that maintain their ordered struc-
ture (16). Therefore, it is expected that the binary compounds involve more symmetrical 
and ordered structures along with higher intermolecular forces between molecules within 
the molecular lattice than the ternary systems.
DSC thermograms (Fig. 2) were generally in support of melting point data and pro-
vided further details regarding the melting behavior of the various products. The case of 
binary and ternary salts involving ASA and PCMA is discussed in more detail here (Fig. 
Table I. Melting points, solubility and log P values of CP-HCl and its different salts
Compound Melting point (°C)
Solubility 
(mg mL–1)a log P
a CP (%) 
[molar ratio]b
CP-PASA-PCMA 159–162 5.4 0.204 55.3 [1:1:1]
CP-ASA-PCMA 196–199 2.8 0.322 35.6 [1:1:2]
CP-BA-PCMA 215–217 1.2 0.544 61.2 [1:1:1]
CP-PASA 206–207 1.5 0.721 65.1 [1:1]
CP-ASA 122–126 1.8 0.920 24.6 [1:4]
CP-BA 234–236 2.0 0.863 72.3 [1:1]
CP-PCMA 224–227 1.5 0.716 61.9 [1:2]
CP-HCl 317–319 27.9 –0.222 –
a Apparent log P (standard error for all measurements < 3 %). 
b Determined by HPLC.
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2b). The thermograms in the studied temperature range, for the free parent compounds: 
CP-HCl, ASA, and PCMA showed clear endotherms at about 145, 140 and 240 °C (sharp), 
resp. However, the binary salt CP-ASA and CP-PCMA showed only sharp peaks at 115 and 
225 °C, resp., which might serve as good evidence of the formation of new entities (the 
salts). For the ternary system (CP-ASA-PCMA), however, the thermogram was showing 
two different endotherms at about 80 and 145 °C. Additionally, an exothermic peak was 
observed in the thermogram of the ternary product CP-ASA-PCMA at about 155 °C which 
is suggestive of structural rearrangement after initial melting. 
The additional exothermic peak (suggestive of molecular rearrangement) was indeed 
a characteristic feature in the DSC thermograms of the ternary products (Figs. 2a-c). This 
was consistent with our suggestion that the ternary complexes resulted in less ordered 
molecular structures compared to binary complexes and, therefore, might undergo mole-
cular rearrangement once in the liquid state (after initial melting). 
CP content, solubility and log P values of the prepared salts. – The content of CP in each of 
the products was assayed using the HPLC method (8) when CP was very well separated 
from the employed counterion (organic acid). Although ion-exchange chromatography is 
the most frequently reported method for the separation of the counterions of organic salts, 
other chromatographic modes including reversed-phase and mixed phases have also been 
reported to be successful (17–19).
In this study, the reversed-phase column was found successful in separating CP from 
counteranions. This was verified by showing that the counteranions having good UV 
 absorptivity were eluted at a significantly lower retention time than CP. Representative 
chromatograms showing the separation of CP from the organic anions are presented in 
Fig. 2. DSC thermograms of the parent moieties and binary and ternary salts obtained from CP and: a) PASA, 
b) ASA, c) BA and d) PCMA.
a)                                                                              b)
c)                                                                              d)
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Fig. 3a. The method showed precision with RSD < 2.5 % at different concentration levels, 
and accuracy within the range 98–103 %. Additionally, the HPLC method was linear over 
the concentration range of 5–50 µg mL–1 for CP, with R2 > 0.998. Results expressed as a 
percentage of CP in the products are presented in Table I. The differences between the 
experimentally found percentage of CP and their expected values (i.e., 100 % assuming the 
product was composed of CP only) were considered to correspond to the accompanying 
anionic species. Therefore, by using the molar mass of CP and that of the different anions 
employed, it was possible to estimate the likely molar association ratios between CP and 
anions that fit the determined percentage of CP within a margin of error < 4 %.
The data in Table I revealed that, as expected, only BA and PASA formed 1:1 salts with 
CP, while PCMA and ASA associated with CP at ratios of 2:1 and 4:1, resp. When PCMA 
existed in solution along with other anions, ternary complexes involving PCMA, CP and 
other anions were formed. All of these ratios (estimates based on HPLC determination of 
CP content in the product) were further supported by NMR spectra for the products (vide 
infra).
Aqueous solubility of most products was significantly lower (~10 times) than that of 
the parent CP-HCl (Table I). log P values were also higher for the prepared salts compared 
to CP-HCl. The binary CP-ASA salt had the highest log P (0.92) whereas the ternary CP-
PASA-PCMA salt showed the lowest log P (0.204). The observed differences in solubility 
and log P values between the seven prepared CP salts and the parent free CP-HCl provide 
evidence of the formation of salts and maintenance of their structures in solution; if the 
salts did not hold in solution then log P values would not be expected to change. Our 
 results indicate that the formation of different salts of CP is clearly affecting its physico-
chemical properties which depend mainly on the type of the organic anion used. It is 
Fig. 3. a) Representative chromatograms of various prepared salts showing the separation of CP (tr at 
about 6 min) from the other organic anions (early eluting peaks at ~2.5 min). b) Representative chro-
matograms of the standard CP-HCl employed for the construction of the calibration curve (2–50 µg 
mL–1 range).
a)                                                                                    b)
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 expected that the noted differences in log P values among the products might result in 
different permeation of the drug through bacterial cell wall with a possibility of attaining 
optimal effects.
1H NMR and FTIR spectroscopy. – 1H NMR spectra were obtained for all products and 
CP-HCl (Fig. S1). A summary of the obtained peaks and their assignments for all products 
is also presented in Table II. The 1H NMR for the binary and the ternary salts of ASA (as 
an example) with CP is presented in Fig. 4.
Generally, spectra of the prepared salts accorded well with those previously reported 
for their parent compounds, CP and the four organic anions (20). Thus aromatic protons 
number 2, 5 and 8 in CP (Fig. 1) resonated at 8.69 (singlet), 7.75 (doublet) and 7.64 (doublet) 
ppm, resp. (Fig. 4a). Assignments of protons on ASA and its related products were based 
on literature reports on ASA in addition to the characteristic multiplicity pattern for 
each proton and the relative peak area for each signal (Fig. 4b), e.g., proton No. 5 on ASA 
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 appeared as dd at highest δ (ppm) which corresponds to the signal at 7.92 ppm in the 
 spectrum of CP-ASA. It is noteworthy that each proton of ASA appeared at two close 
 frequencies with similar multiplicities. According to relative peak areas for protons of ASA 
and those for CP it could be concluded that four molecules of ASA were bound to one 
molecule of CP, albeit with an asymmetrical manner (hence the duplication of proton 
 signals in NMR). None of the protons of CP appeared to be significantly shifted, but that 
for proton number 2 became a doublet instead of a singlet. A structural arrangement that 
fits the NMR data can be proposed. Two molecules of ASA seem to bind to CP through 
dimer formation with the carboxyl group of CP, therefore minimum or no shift is antici-
pated for their aromatic protons in the NMR spectrum. The other two molecules, however, 
are likely to be aligned with the fluorinated ring of CP in a manner that allows protons 3 
and 4 of ASA to lie close to the aromatic ring of CP, leading to the observed shifts. At the 
same time, such an arrangement would allow for acid-base interaction between the 
 carboxyl of ASA and the basic amino group of piperazine ring. 
Table II. Summary of 1H NMR data within the aromatic region for the formed CP products
Compound Chemical shift (cm
–1) (multiplicity, number of protons, assigned protons 
within the structure)
Ciprofloxacin-HCl 8.69 (s, 1H, no. 2); 7.75 (d, 1H, no. 5); 7.64 (d, 1H, no. 8) 
CP-ASA
CP protons: 8.68 (s, 1H, no.2); 7.96 (t, 1H, no. 5); 7.59 (d, 1H, no. 8)
ASA protons: 6.89 (q, 2H, no. 2 and 4); 7.19 (d, 1H, no. 2); 7.38 (t, 1H, no. 4); 
7.45 (t, 1H, no. 3); 7.63 (t, 1H, no. 3); 7.77 (dd, 1H, no. 5 ); 7.92 (dd, 1H, no. 5 )
CP-PCMA
CP protons: 7.51 (s, 1H, no. 2); 7.2 (d, 1H, no. 5); 6.7 (d, 1H, no. 8)
PCMA protons: 7.51 (d, 2H, no. 2 and 6); 7.48 (s, 1H, no. 8 ); 6.8 (d, 2H, no. 3 
and 5); 6.29 (d, 1H, no. 7)
CP-ASA-PCMA
CP protons: 7.5 (overlap, 1H, no. 2); 7.18 (d, 1H, no. 5); 6.64 (overlap, 1H, no. 8)
ASA protons: 7.96 (d, 1H, no. 5); 7.69 (d, 1H, no. 3); 7.61 (d, 1H, no. 4); 6.64 
(overlap, 1H, no. 2)
PCMA protons: 7.5–7.6 (m, overlap, 3H, no. 2, 6 and 8); 6.75 (d, 2H, no. 3 and 
5); 6.3 (d, 1H, no. 7)
CP-BA
CP protons: 8.67 (s, 1H, no. 2); 7.94 (overlap, 1H, no. 5); 7.59 (d, 1H, no. 8)
BA protons: 7.94 (d, 2H, no. 1 and 6); 7.55 (d, 1H, no. 4); 7.48 (d, 2H, no. 3 and 5)
CP-BA-PCMA
CP protons: 8.65 (s, 1H, no. 2); 7.94 (d, 1H, no. 5); 7.5 (overlap, 1H, no. 8)
BA protons: 7.94 (d, 2H, no. 2 and 6); 7.5 (m, 3H, no. 3, 4 and 5)
PCMA protons: 7.51 (d, 3H, no. 2 , 6 and 8); 6.75 (d, 2H, no. 3 and 5); 6.29 (d, 
1H, no. 7)
CP-PASA
CP protons: 8.65 (s, 1H, no. 2); 7.94 (d, 1H, no. 5); 7.59 (d, 1H, no. 8)
PASA protons: 7.35 (d, 1H, no. 6); 5.98 (d, 1H, no. 5); 5.9 (s, 1H, no. 3)
CP-PASA-PCMA
CP protons: 8.67 (s, 1H, no. 2); 7.9 (d, 1H, no. 5); 7.57 (d, 1H, no. 8)
PASA protons: 7.38 (d, 1H, no. 6); 5.97 (d, 1H, no. 5); 5.88 (s, 1H, no. 3)
PCMA protons: 7.1 (d, 3H, no. 2, 6 and 8); 7.4 (s, 1H), 6.8 (d, 2H, no. 7 )
ASA – acetylsalicylic acid, BA – benzoic acid, CP – ciprofloxacin, PASA – p-aminosalicylic acid, PCMA – p-coumaric 
acid
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For the spectrum of CP-PCMA (Fig. 4c), the characteristic peaks for protons number 5 
and 8 of CP appeared clearly, though with dramatic upfield shifts. The peak for proton 
number 2 of CP appeared to completely overlap with that for the characteristic mixed peak 
for PCMA (at ~7.5 ppm). The integrated peak area ratios most likely accord with two mole-
cules of PCMA bound to one molecule of CP. The observation that the protons of CP were 
significantly shifted to a lower frequency (more shielded) suggests that each of the aro-
matic rings of CP is aligned at some angle with the aromatic ring of PCMA (one molecule 
of PCMA for each CP ring) so that the aromatic protons of CP would lie in the middle of 
the aromatic ring.
For the product CP-ASA-PCMA (Fig. 4d), the formation of the ternary molecular struc-
ture is evidenced by the characteristic peaks for the protons of CP, ASA and PCMA. The 
pattern for ASA protons was significantly different from that observed for CP-ASA (binary 
salt) in the sense that only one signal for each proton on ASA was observed, while in ASA-
PCMA two peaks were observed for each proton reflecting different molecular arrange-
ment. While some of the ASA protons were shifted to a lower frequency, protons of PCMA 
and CP did not show significant shifts. However, according to integrated peak area ratios 
of properly resolved protons signals, the estimated association ratio between the three 
compounds accord with 1:1:2 (CP:ASA:PCMA).
For CP-BA (Fig. S1), the protons of both components were observed with no significant 
shifts in their resonances. Integrated peak area ratios suggested a ratio of association of 1:1 
between the two. The ternary product CP-BA-PCMA was also shown to form as the pro-
tons of the three original compounds were evident in the NMR spectrum and without 
significant shifts of resonances. Peak area calculations suggested the formation of a 1:1:1 
ternary molecular association product, most likely one of the acidic moieties through the 
acid-base association with the amino group of CP and the other molecule as a carboxylic 
acid dimer with the carboxylic acid of CP.
The NMR spectrum of CP-PASA (Fig. S1) was simple and straightforward with mini-
mum overlapping of signals. All protons of both compounds were shown in the spectrum 
with a clear association ratio of the two equal to 1:1. The ternary product involving PASA 
was also evident with an obvious binding ratio of 1:1:1 with minimum shifts in the protons 
of CP and PASA. However, significant shifts for some protons of CPMA could be observed, 
i.e., proton No. 7 which appeared to become more shielded upon the ternary structure 
formation. Overall, NMR spectra provided clear evidence on the formation of binary and 
ternary salts as products that was in accordance with the results of HPLC ratio analysis.
FTIR spectra for CP-HCl, each anionic component as well as the products were 
 obtained (Fig. 5). FTIR spectra for the binary products (CP plus any of the employed 
 anions), and ternary products (CP plus PCMA, plus one of the remaining anions) showed 
clear differences from each of free CP and/or individual anion (Fig. 5). A summary of the 
major functional groups’ peaks for CP as well as each of the employed anions and the 
combination products are presented in Table III.
The most prominent absorption bands of CP were shown at 3540 (mainly N-H stretch-
ing), 1710 (C=O, carboxylic), 1620 (C=O, ketone or N-H functional groups) cm–1 which 
 accords well with the previous reports (21–24). Reflections for the dimeric carboxyl O-H 
stretch, and the protonated amino group are seen as multiple bands in the range of 2500–
2700 cm–1 (21–24).
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Fig. 5. FTIR spectra (double bond region, 1400–2000 cm–1) of the binary and ternary salts obtained 
with CP and: a) PASA, b) ASA, c) BA, d) PCMA.
Table III. Major functional groups peaks in FTIR spectra of CP, organic anions and their products
Compound
Main functional groups, wavenumber (cm–1)
N-H O-H (phenol) O-H (acid) C=O Quinolone carbonyl (C=O)
CP 3530–3400 – 2470–2700 1708 1620 
BA – – – 1608 –
PCMA – 3375 (b) 2600–3375 (b) 1670 –
CP-BA 3425 – – 1731 (w) 1621 (s) 
CP-PCMA 3389 (m,b) – 2600–3389 1676 (s) 1654 
CP-BA-PCMA – – – 1689 1631, 1629 
ASA – 2896 (m,b) – 1753 (m), 1683 (s) –
CP-ASA – 2854 (m,b) – 1753 (w), 1687 (s) –
CP-ASA-PCMA – 3037 (m,b) 2400–3037 (m) 1691 (m) 1630 (m) 
PASA – 2800–3500 (w,b) 1627 –
CP-PASA 3414 (w,b) – 2400–3414 (w,b) 1704 (m) 1629 (s), 1621 (s)
CP-PASA-PCMA – 3460 (m,b) 2400–3460 (w,b) 1674 1635
ASA – acetylsalicylic acid, BA – benzoic acid, CP – ciprofloxacin, PASA – p-aminosalicylic acid, PCMA – p-coumaric acid
b – broad, m – medium, s – strong, w – weak
a)                                                                               b)
c)                                                                               d)
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Of the most obvious changes in the IR spectra were the changes noticed in > 3100 cm–1 
regions, which is mainly assigned to the exchangeable protons OH and NH stretching. 
When compared to CP, peaks in such regions became generally broader and less intense 
upon the formation of the product suggesting stronger hydrogen bond structure. The chara-
cteristic absorption band for carboxylic carbonyl at 1708 cm–1 disappeared completely or 
shifted to a lower frequency for most of the salts of CP and with employed organic acids, 
either as binary or ternary products (Fig. 5 and Table III). However, the magnitude of such 
changes varied between products with the minimum being observed for the binary salt 
involving CP and PCMA (Fig. 5d). The characteristic carbonyl absorption bands for each 
organic acid (1670–1750 cm–1) were observed in the relevant binary products (CP-organic 
anion) with some minor shifts. However, in ternary products involving CP, PCMA and one 
of the other organic acids, only the characteristic absorption band relevant to the carbonyl 
group of PCMA was observable while that of the other anion disappeared. Thus one might 
think that in these cases the actual product simply consists of only CP and PCMA while 
the other added anion remained in solution and did not participate in the formation of the 
product. However, the overall spectra for binary and ternary products were obviously 
different (Fig. 5). Additionally, NMR data showed unequivocally the presence of the three 
Fig. 6. a) X-ray diffraction pattern of CP-PASA. b), c) and d) are microscopic images of CP-PASA, CP-BA-
PCMA, and CP-BA, resp.
                a)
   b)                                                   c)                                                d)
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components in cases of ternary products (CP, PCMA and other organic anions). Although 
binary salts of CP with carboxylic acids have been frequently reported, to the best of our 
knowledge the tri-molecular salts are reported for the first time in this study.
X-ray diffraction. – X-ray diffraction patterns were obtained for some of the crystalline 
products (CP-BA-PCMA, Fig. 6a) along with microscopic images for the crystals of CP- 
-PASA, CP-BA-PCMA, and CP-BA (Figs. 6b-d). The crystalline nature of the products and 
the obtained X-ray diffraction pattern reflect a good level of purity due to the existence of 
very sharp and relatively few peaks, which enhances the confidence in the homogeneity 
and thus the purity of the products.
Antimicrobial activity. – A summary of the obtained MIC values for the prepared salts 
is presented in Table III. Ciprofloxacin (CP-HCl) was used as a reference compound.
Based on the presented results (Table IV) none of the individual four anions exhibited 
interesting antibacterial activity against the two examined strains, Staphylococcus aureus 
and Staphylococcus epidermidis. The results for CP were generally comparable to values 
previously reported (25, 26). CP showed four times higher antimicrobial activity against S. 
epidermidis compared to S. aureus. Different products showed different activities towards 
S. aureus and S. epidermidis. CP-BA exhibited higher activity against S. aureus while CP-BA- 
-PCMA, CP-ASA, CP-ASA-PCMA, and CP-PASA were more active against S. epidermidis. 
Most of the salt products (5 out of 7) had either comparable or higher antimicrobial activ-
ity than CP against both strains. The most active compounds against S. epidermidis and S. 
aureus were CP-PASA (MIC = 1 mmol L–1) and CP-PCMA (MIC = 5 mmol L–1), resp., which 
were about fourteen times more potent than native CP. Our results confirm that the pre-
pared CP-salts modulate the antimicrobial activity of CP, favorably, in most cases. The 
observed improvement in their antimicrobial effect compared to CP might be due to their 
Table IV. Antimicrobial activity (MIC) for the examined compounds
Compound MIC (Staphylococcus epidermidis) (mmol L–1)a
MIC (Staphylococcus aureus) 
(mmol L–1)a
Ciprofloxacin (CP-HCl) 17 68
BA > 1639 > 1639
PCMA 1219 1219
ASA > 1111 > 111








CP – ciprofloxacin, ASA – acetylsalicylic acid, BA – benzoic acid, PASA – p-aminosalicylic acid, PCMA – p-coumaric 
acid 
a Mean values from triplicate measurements repeated twice for each bacterium and each tested compound.
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increased lipophilicity which in turn expectedly enhances permeation through the cell 
membrane with consequent enhancement of antimicrobial activity. Another possible 
 explanation might include intact ion pair which interacts with some important cellular 
targets in a different way.
In order to get further insights, a plot between the obtained MIC values and the 
 experimentally measured log P values was established (Fig. 7a). Interestingly, Fig. 7a shows 
that, with both S. aureus and S. epidermidis, there was an optimum value of log P that pro-
vided the best antimicrobial activity. The value was almost the same with both strains and 
was around 0.75. Our finding is consistent with the previous work of Vázquez et al. (27) 
Fig. 7. a) A plot of MIC values of different products between their measured log P values. b) A plot of 
MIC between the binding constants of the products. Each point in the plot represents a different 
product.
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who studied the relationship between the antimicrobial activity of quinolones and their 
partition coefficient values and reported similar tendencies and the existence of an opti-
mum value of log P for maximum antimicrobial activity against E. coli. In their study, the 
optimum value of the partition coefficient was ~2.5 which is equivalent to log P of 0.4. 
However, in their study, the optimization of partition coefficient values of quinolone com-
pounds was only achievable through the synthesis of new derivatives of CP having cova-
lently attached side chains of various lengths of (27). In our study, we demonstrate the 
possibility of achieving optimum log P of CP derivatives simply through the proper choice 
of the counteranion to form ion pair (salt).
Binding of CP salts to DNA. – CP had been shown to bind to DNA influencing its mode 
of antimicrobial action (28, 29). Therefore, we decided to study the ability of the various 
prepared salts to interact with calf thymus DNA (CT DNA). UV/VIS spectroscopic titration 
of samples of CP with CT DNA revealed a progressive spectral shift at ~323 nm as more of 
DNA was added (Fig. S2). DNA itself shows no absorption at 323 nm, therefore, the 
 observed shift made us inclined to believe of drug-DNA complex formation and called for 
estimation of the respective binding isotherm and binding constant.
DNA-drug binding constants obtained for the various derivatives of CP revealed 
 almost one order of magnitude between the largest (7.1 × 105 L mol–1) and the weakest bind-
ing derivatives (8.3 × 104 L mol–1) (Fig. 7b). This prompted us to search for a potential cor-
relation between the binding constant and the observed MIC values against the two tested 
microorganisms. When log MIC values for each CP salt were plotted against their corre-
sponding DNA binding constants, a reasonable linear correlation was shown with a cor-
relation coefficient of 0.90 for S. epidermidis but there was no reasonable correlation for S. 
aureus (Fig. 7b). The strong correlation noticed herein between the DNA binding constant 
of the CP salts and their observed MIC values against S. epidermidis supports the previous 
reports (30) of the potential importance of DNA binding ability of quinolones in their 
mechanism of action. Although the mechanism of action for quinolones is generally 
 accepted as DNA gyrase inhibitors, some reports have demonstrated a direct correlation 
between DNA binding constant and the measured antimicrobial activity (31). This is in 
line with our findings where a clearly strong correlation was noticed with S. epidermidis. 
The provided data might suggest that the prepared salts remained as intact ion pairs even 
inside the microbial cells.
CONCLUSIONS
Novel binary and ternary salts of CP were prepared using four different organic 
 anions. The counteranions played an important role in dictating important physical, thermal 
and antimicrobial properties of CP. The prepared salts have been adequately characterized 
and evaluated for their antimicrobial activities. Our findings have shown that the prepared 
salts of CP are maintained at very low concentrations sufficient to affect bacterial cells. The 
prepared derivatives have improved physicochemical properties compared to parent CP 
and exhibited a range of lipophilicities that resulted in differences in their antimicrobial 
activities. Therefore, the products were shown able to modulate the antimicrobial activity 
of the parent CP.
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Our results suggested that lipophilicity might correlate with antimicrobial activity 
and showed that an optimum value of lipophilicity seemed to be necessary to maximize 
the antimicrobial activity. While the main influence of lipophilicity appears to be by 
 improving the permeation through the cell membrane, our study has suggested that the 
intact salt structure is likely to get into the cell and, thus, might interact with the bacterial 
DNA leading to differences in the antimicrobial activity in a manner proportional to the 
extent of DNA binding. The improved antibacterial activity of the prepared salts is of 
 particular interest, especially in topical and ophthalmic preparations.
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